MENA v. TEVA PHARMACEUTICALS USA, INC. et al
JASMINE MENA |
Teva Pharmaceuticals USA Inc, Teva Women's Health LLC doing business as Teva Women's Health Inc, DURAMED PHARMACEUTICALS, INC. A DIVISION OF BARR PHARMACEUTICALS, INC. doing business as TEVA WOMEN'S HEALTH, Teva Women's Health Inc, Teva Women's Health LLC, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Coopersurgical Inc and The Cooper Companies Inc |
1:2022cv02354 |
June 14, 2022 |
US District Court for the Northern District of Georgia |
Leigh Martin May |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 Diversity-Product Liability |
Both |
Docket Report
This docket was last retrieved on July 14, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 18 AMENDED COMPLAINT Short Form Complaint against Coopersurgical Inc, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, The Cooper Companies Incwith Jury Demand filed by JASMINE MENA. (Attachments: #1 Civil Cover Sheet, #2 Summons Coopersurgical, Inc., #3 Summons Teva Branded Pharmaceutical Products R&D, Inc., #4 Summons The Cooper Companies, Inc., #5 Summons Teva Pharmaceuticals USA, Inc., #6 Summons Teva Women's Health, LLC)(Kassan, Randi) Please visit our website at http://www.gand.uscourts.gov/commonly-used-forms to obtain Pretrial Instructions and Pretrial Associated Forms which includes the Consent To Proceed Before U.S. Magistrate form. |
|
Filing 16 Case transferred in from District of Pennsylvania Eastern; Case Number 2:22-cv-02115. Original file certified copy of transfer order and docket sheet received. |
Civil Case Terminated. (kxm) |
Notification of Docket Correction: Case opened with the wrong case number. The correct case number is 1:22-cv-2354 LMM (aar) |
Filing 15 Certified Copy of Conditional Transfer Order 46. Re: Order that, pursuant to Rule 7.1 of the Rules of Procedure of the U.S. Judicial Panel on MDL, the action is transferred under 28 USC sec. 1407 to the Northern District of Georgia for the reasons stated in the order of December 16, 2020, and, with the consent of that court, assigned to the Hon. Leigh Martin May. (fdc) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Case transferred to U.S. District Court Northern District of Georgia via CM/ECF electronic transfer. (fdc) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 14 ANSWER to Complaint by TEVA WOMEN'S HEALTH INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 13 ANSWER to Complaint by TEVA PHARMACEUTICALS USA, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 12 ANSWER to Complaint by TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 11 ANSWER to Complaint by COOPERSURGICAL, INC.,.(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 10 ANSWER to Complaint by THE COOPER COMPANIES, INC.,.(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 9 Original Record together with certified copy of docket entries received from Court of Common Pleas of Philadelphia County. (ke) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 8 ANSWER to Complaint by TEVA WOMEN'S HEALTH, LLC., individually and as successor in interest to TEVA WOMEN'S HEALTH, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 7 Disclosure Statement Form pursuant to FRCP 7.1 by TEVA WOMEN'S HEALTH, LLC., individually and as successor in interest to TEVA WOMEN'S HEALTH, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 6 Disclosure Statement Form pursuant to FRCP 7.1 by TEVA WOMEN'S HEALTH INC., individually, and as successor in interst to, DURAMED PHARMACEUTICALS, INC., a division of Barr Pharmaceuticals, Inc..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 5 Disclosure Statement Form pursuant to FRCP 7.1 by TEVA PHARMACEUTICALS USA, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 4 Disclosure Statement Form pursuant to FRCP 7.1 by TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 3 Disclosure Statement Form pursuant to FRCP 7.1 by COOPERSURGICAL, INC.,.(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 2 Disclosure Statement Form pursuant to FRCP 7.1 by THE COOPER COMPANIES, INC.,.(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Filing 1 NOTICE OF REMOVAL by TEVA WOMEN'S HEALTH, LLC., individually and as successor in interest to TEVA WOMEN'S HEALTH, INC., TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., THE COOPER COMPANIES, INC.,, TEVA PHARMACEUTICALS USA, INC., COOPERSURGICAL, INC.,, TEVA WOMEN'S HEALTH INC., individually, and as successor in interst to, DURAMED PHARMACEUTICALS, INC., a division of Barr Pharmaceuticals, Inc. (Filing fee $ 402 receipt number APAEDC-15951902), filed by TEVA WOMEN'S HEALTH, LLC., individually and as successor in interest to TEVA WOMEN'S HEALTH, INC., TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., THE COOPER COMPANIES, INC.,, TEVA PHARMACEUTICALS USA, INC., COOPERSURGICAL, INC.,, TEVA WOMEN'S HEALTH INC., individually, and as successor in interst to, DURAMED PHARMACEUTICALS, INC., a division of Barr Pharmaceuticals, Inc..(RUBENSTEIN, BRIAN) [Transferred from Pennsylvania Eastern on 6/14/2022.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.